A new publication referencing ghrelin receptor activity appeared on Research Square on June 25, 2026. The paper is titled "Striosomal ghrelin receptor activity controls reward-cost integration." Ibutamoren is known as a ghrelin receptor agonist, which is regulatory approved status is listed as approved. This entry reflects a publication event only, with no additional findings summarized here. The listing includes the title, journal, and date as provided. No results, conclusions, or data points beyond the title have been disclosed in this event record. Readers should note that Research Square hosts preprints, and content may be subject to further peer review. No efficacy or safety claims are made in this brief. The publication is indexed under PubMed ID 42396509. For more information on the compound itself, readers can consult the compound overview for additional context.
New Ibutamoren-Related Publication Posted on Research Square
Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.
See the full ibutamoren overview
Source: https://pubmed.ncbi.nlm.nih.gov/42396509/